Certified by Founder Lodge
ATEM Capital
United States - New York, New York
INVESTOR
1 Disclosed Funding Rounds $100,000,000
1 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
ATEM Capital manages evergreen Life Sciences investment fund - Health Square Fund (HSF). HSF acts as a consolidator of capital flows from the Emerging Markets and invests into the biotech inn
| Company | Date | Round | Raised |
|---|---|---|---|
Triumvira Immunologics, Inc. |
March, 17 ,2022 | Series A | $100,000,000 |
Triumvira Immunologics, Inc.
dezerv.
FalconX
Kristal.AI
Finary
Savart
IORGANBIO | $2,000,000 | (Oct 30, 2025)
Sparrow BioAcoustics | $10,000,000 | (Oct 30, 2025)
Vesence | $9,000,000 | (Oct 30, 2025)
Homecourt | $8,000,000 | (Oct 30, 2025)
Reflectiz | $22,000,000 | (Oct 30, 2025)